Vaccination against schistosomiasis: a difficult challenge Newsletter Article 05 February 2013 Pages: 5 - 5
Debate over post-transplant switch from cyclosporin to azathioprine Newsletter Article 05 February 2013 Pages: 5 - 5
QOL impact of immunosuppressants after transplantation Newsletter Article 05 February 2013 Pages: 7 - 7
A novel therapeutic approach for diabetic nephropathy? Newsletter Article 05 February 2013 Pages: 8 - 8
Opportunities abound for integrin antagonists Gill Higgins Newsletter Article 05 February 2013 Pages: 9 - 11
IL-10 has anti-inflammatory/immunomodulatory potential Newsletter Article 05 February 2013 Pages: 11 - 11
IFN-α-n1 extends survival in chronic myeloid leukaemia Newsletter Article 05 February 2013 Pages: 12 - 12
Focusing on zileuton as it moves closer to FDA approval Rodger Hall Newsletter Article 05 February 2013 Pages: 13 - 14
Citalopram reduces aggressive incidents in schizophrenia Newsletter Article 05 February 2013 Pages: 14 - 14
Ceftazidime vs ceftriaxone + tobramycin in nosocomial infection Newsletter Article 05 February 2013 Pages: 16 - 16
Bicalutamide + gonadorelin agonist better in prostate cancer Newsletter Article 05 February 2013 Pages: 16 - 16
Adjuvant thiamine beneficial in long-term furosemide therapy Newsletter Article 05 February 2013 Pages: 19 - 19
IMMP report confirms omeprazole ‘is very well tolerated’ Newsletter Article 05 February 2013 Pages: 21 - 21
European osteoporosis market set to increase by 50% Newsletter Article 05 February 2013 Pages: 22 - 22